Development of an improved vaccine for anthrax.
作者信息
Leppla Stephen H, Robbins John B, Schneerson Rachel, Shiloach Joseph
机构信息
National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland 20892-4350, USA.
出版信息
J Clin Invest. 2002 Jul;110(2):141-4. doi: 10.1172/JCI16204.
Abstract
摘要
相似文献
1
Development of an improved vaccine for anthrax.
J Clin Invest. 2002 Jul;110(2):141-4. doi: 10.1172/JCI16204.
2
Anthrax. From bioweapons backwater to main attraction.
Science. 2003 Apr 18;300(5618):414-5. doi: 10.1126/science.300.5618.414.
3
Progress and novel strategies in vaccine development and treatment of anthrax.
Immunol Rev. 2011 Jan;239(1):221-36. doi: 10.1111/j.1600-065X.2010.00969.x.
4
Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
Biochim Biophys Acta. 2013 Mar;1830(3):2804-12. doi: 10.1016/j.bbagen.2012.11.006.
5
Tackling anthrax.
Nature. 2001 Nov 8;414(6860):160-1. doi: 10.1038/35102660.
6
Microbiology. A binding contract for anthrax.
Science. 2002 Jul 12;297(5579):201-2. doi: 10.1126/science.1074590.
7
Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
FEMS Immunol Med Microbiol. 2012 Aug;65(3):505-9. doi: 10.1111/j.1574-695X.2012.00974.x. Epub 2012 May 21.
8
Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
PLoS One. 2015 Jul 24;10(7):e0130952. doi: 10.1371/journal.pone.0130952. eCollection 2015.
9
A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13601-6. doi: 10.1073/pnas.0405557101. Epub 2004 Sep 1.
10
Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
Vaccine. 2005 Dec 1;23(48-49):5688-97. doi: 10.1016/j.vaccine.2004.11.077. Epub 2005 Feb 5.
引用本文的文献
1
Human Exposure to Naturally Occurring in the Kars Region of Eastern Türkiye.
Microorganisms. 2024 Jan 14;12(1):167. doi: 10.3390/microorganisms12010167.
2
Aerosolized Intratracheal Inoculation of Recombinant Protective Antigen (rPA) Vaccine Provides Protection Against Inhalational Anthrax in B10.D2-Hc Mice.
Front Immunol. 2022 Jan 26;13:819089. doi: 10.3389/fimmu.2022.819089. eCollection 2022.
3
Assembly and Function of the Anthrax Toxin Protein Translocation Complex.
Subcell Biochem. 2021;96:563-577. doi: 10.1007/978-3-030-58971-4_18.
4
Current Status and Trends in Prophylaxis and Management of Anthrax Disease.
Pathogens. 2020 May 12;9(5):370. doi: 10.3390/pathogens9050370.
5
A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague.
mBio. 2018 Oct 16;9(5):e01926-18. doi: 10.1128/mBio.01926-18.
6
Green Tea Catechin-Inactivated Viral Vaccine Platform.
Front Microbiol. 2017 Dec 12;8:2469. doi: 10.3389/fmicb.2017.02469. eCollection 2017.
7
Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
Clin Vaccine Immunol. 2017 Nov 6;24(11). doi: 10.1128/CVI.00165-17. Print 2017 Nov.
8
A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, and .
Front Immunol. 2017 Jun 26;8:687. doi: 10.3389/fimmu.2017.00687. eCollection 2017.
9
Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.
Vaccine. 2017 Jun 8;35(26):3416-3422. doi: 10.1016/j.vaccine.2017.05.006. Epub 2017 May 11.
10
Biomarkers Discovery for Colorectal Cancer: A Review on Tumor Endothelial Markers as Perspective Candidates.
Dis Markers. 2016;2016:4912405. doi: 10.1155/2016/4912405. Epub 2016 Nov 14.
本文引用的文献
1
Field Evaluation of a Human Anthrax Vaccine.
Am J Public Health Nations Health. 1962 Apr;52(4):632-45. doi: 10.2105/ajph.52.4.632.
2
Biological products; bacterial vaccines and toxoids; implementation of efficacy review. Final rule and final order.
Fed Regist. 2004 Jan 5;69(2):255-67.
3
Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures.
Appl Microbiol. 1963 Jul;11(4):330-4. doi: 10.1128/am.11.4.330-334.1963.
4
Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man.
J Bacteriol. 1963 Jan;85(1):230-6. doi: 10.1128/jb.85.1.230-236.1963.
5
Studies on immunity in anthrax. V. Immunizing activity of alum-precipitated protective antigen.
J Immunol. 1954 Dec;73(6):387-91.
6
Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity.
Nat Biotechnol. 2002 Jun;20(6):597-601. doi: 10.1038/nbt0602-597.
7
A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection.
Infect Immun. 2002 Mar;70(3):1653-6. doi: 10.1128/IAI.70.3.1653-1656.2002.
8
Protein Explorer: easy yet powerful macromolecular visualization.
Trends Biochem Sci. 2002 Feb;27(2):107-9. doi: 10.1016/s0968-0004(01)02008-4.
9
Anthrax spores make an essential contribution to vaccine efficacy.
Infect Immun. 2002 Feb;70(2):661-4. doi: 10.1128/IAI.70.2.661-664.2002.
10
In vitro correlate of immunity in a rabbit model of inhalational anthrax.
Vaccine. 2001 Sep 14;19(32):4768-73. doi: 10.1016/s0264-410x(01)00234-1.
Zotero 插件